Skip to main content
OpenTrials
Completed

NCT Number: NCT02760693

Bipolar Cohort Neunkirchen, Final Statement

monitoring system and data base for long term follow up of various treatment strategies in a naturalistic setting of recurrent affective disorders (unipolar, bipolar) open study design, prospective & retrospective

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

BIPOLAR Zentrum Wiener Neustadt

Wiener Neustadt, Lower Austria, 2700, Austria

About this study

all hospitalized patients of a defined mixed urban and more rural area were consecutively interviewed at admission and entered into the data base. at discharge they gave written informed consent for further tracking and interviews.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • bipolar

Exclusion criteria

  • all other diagnoses

Treatment and study plan

Primary outcomes

  1. relapses, hospital admissions, number of participants with adverse events as a measure of safety and tolerability

    Time frame: patients from the cohort are contacted once a year (1 to 6 years)

Sponsors and collaborators

Lead sponsor

Österreichische Gesellschaft für Bipolare Erkrankungen

Other

Registry information

Official study title

SPICS (Secure Platform for Integrating Clinical Studies) for Recurrent (Bipolar) Affective Disorders for Long Term Follow up Treatment Regiments and Outcome in a Natural Setting

Important dates

Study start
2000
Primary completion
2016
Study completion
2016
First posted
May 4, 2016
Registry last updated
May 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.